Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew I Chin

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
Hepatitis B virus vaccine response in hemodialysis: baseline patient characteristicsAndrew I Chin
Kidney Medicine|August 1, 2020
Does Rescheduling a Missed In-Center Hemodialysis Treatment Improve Clinical Outcomes?Nasim Wiegley, Andrew I Chin
Kidney International Reports|June 2, 2018
The Author RepliesNiti Madan, Andrew I Chin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 2013
In reply to 'Dabigatran pharmacokinetics--implications for treatment'Don N Chang, Andrew I Chin
Journal of the American Society of Nephrology : JASN|May 25, 2013
Ideal cardiovascular health and progression of CKD: perhaps not so "simple"Andrew I Chin, Lorien S Dalrymple
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysisAndrew I Chin, Jane Y Yeun
Plos One|September 18, 2025
Adverse outcomes post-COVID-19 hospitalization among ESRD patients: A retrospective cohort study in 5 California university medical centersMarc Reiterman, Andrew I Chin, Heejung Bang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 4, 2016
Successful Hemodialysis Arteriovenous Fistula Creation in a Patient With Continuous-Flow Left Ventricular Assist Device SupportAndrew I Chin, Kathleen Tong, John P McVicar
STAR Protocols|February 7, 2025
Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacyWen-Hsin Chang, Andrew I Chin, Ching-Hsien Chen
Kidney Medicine|May 29, 2020
Estimating Residual Native Kidney Urea Clearance in Hemodialysis Patients with and without 24-Hour Urine VolumeAndrew I Chin, Vishwa Sheth, Jeehyoung Kim, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Hemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
Hepatitis B virus vaccine response in hemodialysis: baseline patient characteristicsAndrew I Chin
Kidney Medicine|August 1, 2020
Does Rescheduling a Missed In-Center Hemodialysis Treatment Improve Clinical Outcomes?Nasim Wiegley, Andrew I Chin
Kidney International Reports|June 2, 2018
The Author RepliesNiti Madan, Andrew I Chin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 2013
In reply to 'Dabigatran pharmacokinetics--implications for treatment'Don N Chang, Andrew I Chin
Journal of the American Society of Nephrology : JASN|May 25, 2013
Ideal cardiovascular health and progression of CKD: perhaps not so "simple"Andrew I Chin, Lorien S Dalrymple
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysisAndrew I Chin, Jane Y Yeun
Plos One|September 18, 2025
Adverse outcomes post-COVID-19 hospitalization among ESRD patients: A retrospective cohort study in 5 California university medical centersMarc Reiterman, Andrew I Chin, Heejung Bang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 4, 2016
Successful Hemodialysis Arteriovenous Fistula Creation in a Patient With Continuous-Flow Left Ventricular Assist Device SupportAndrew I Chin, Kathleen Tong, John P McVicar
STAR Protocols|February 7, 2025
Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacyWen-Hsin Chang, Andrew I Chin, Ching-Hsien Chen
Kidney Medicine|May 29, 2020
Estimating Residual Native Kidney Urea Clearance in Hemodialysis Patients with and without 24-Hour Urine VolumeAndrew I Chin, Vishwa Sheth, Jeehyoung Kim, et al.
Pageof 3